These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 6013638)
1. [Legislation concerning specialties and pharmaceutical specialty explained by various examples]. Escher A Pharm Acta Helv; 1966 Dec; 41(12):641-57. PubMed ID: 6013638 [No Abstract] [Full Text] [Related]
2. RU 486 and the politics of drug regulation in the United States and France. Kramnick RK Cornell Int Law J; 1992; 25():667-718. PubMed ID: 11656340 [No Abstract] [Full Text] [Related]
3. [Research in pharmaceutical industry, the driving energy of development]. Karsenti R Cah Sociol Demogr Med; 1978; 18(2):59-68. PubMed ID: 679061 [No Abstract] [Full Text] [Related]
4. Progress under the Kefauver-Harris Drug Amendments. Rankin WB Pharmakotherapia; 1964; 2(1):215-22. PubMed ID: 5875717 [No Abstract] [Full Text] [Related]
5. The Food and Drug Administration and freedom of information. Radzius JR Leg Aspects Med Pract; 1978 Jan; 6(1):52-4. PubMed ID: 750805 [No Abstract] [Full Text] [Related]
6. Confronting a new obstacle to reproductive choice: encouraging the development of RU-486 through reform of products liability law. Rubin LA Rev Law Soc Change; 1990-1991; 18(1):131-59. PubMed ID: 11656168 [No Abstract] [Full Text] [Related]
7. Retrospective view of the interfacial relationship of the pharmaceutical industry with the Food and Drug Administration and the United States Pharmacopeia. Hammer HF J Parenter Sci Technol; 1984; 38(4):159-63. PubMed ID: 6491859 [No Abstract] [Full Text] [Related]
8. [COMPARISON OF 2 BILLS ON PHARMACEUTICAL PATENTING IN ITALY, THE EUROPEAN PATENT BILL AND THE GERMAN, ENGLISH AND UNITED STATES LAWS ON PATENTS OF INVENTIONS]. BELLENGHI M Farmaco Prat; 1964 May; 19():240-51. PubMed ID: 14167551 [No Abstract] [Full Text] [Related]
9. Enforcement policy: recalls (including product corrections)--guidelines on policy, procedures, and industry responsibilities. Fed Regist; 1978 Jun; 43(117):26201-21. PubMed ID: 10316619 [No Abstract] [Full Text] [Related]
10. THE NEW DRUG REGULATIONS AND THE PHARMACEUTICAL INDUSTRY. KIRSCH WE Proc West Pharmacol Soc; 1963; 6():48-52. PubMed ID: 14062834 [No Abstract] [Full Text] [Related]
11. Are the drug-regulatory agencies paper villains? Smith T Br Med J; 1980 Nov; 281(6251):1333-5. PubMed ID: 7002251 [No Abstract] [Full Text] [Related]
12. Prescription drug advertising--should states regulate what is false and misleading? Shaeffer J Food Drug Law J; 2003; 58(4):629-48. PubMed ID: 15027454 [No Abstract] [Full Text] [Related]
13. Pharmaceutical patent settlements: the antitrust risks. Balto DA Food Drug Law J; 2000; 55(3):321-41. PubMed ID: 11824464 [No Abstract] [Full Text] [Related]
14. AIDS and drug pricing: in search of a policy. Salbu SR Wash Univ Law Q; 1993; 71(3):691-734. PubMed ID: 11652750 [No Abstract] [Full Text] [Related]
15. [The drama of thalidomide]. Duve A Tidsskr Nor Laegeforen; 1973 Sep; 93(27):2057-9. PubMed ID: 4766388 [No Abstract] [Full Text] [Related]
16. An overview of current programs on drug development and regulation for small ruminants--pharmaceutical industry perspective. Terry M Vet Hum Toxicol; 1993; 35 Suppl 2():12-3. PubMed ID: 8236759 [No Abstract] [Full Text] [Related]
17. Toward more effective drug regulation. Schmidt AM FDA Consum; 1975 Dec-1976 Jan; 9(10):27-9. PubMed ID: 10316532 [No Abstract] [Full Text] [Related]
18. Pharmaceuticals and medical devices: FDA oversight. Chaps NA Issue Brief Health Policy Track Serv; 2009 Jan; ():1-28. PubMed ID: 19297718 [No Abstract] [Full Text] [Related]
19. The economic wisdom of regulating pharmaceutical "freebies". Fisher SH Duke Law J; 1991 Feb; (1):206-39. PubMed ID: 10114416 [No Abstract] [Full Text] [Related]
20. Veterinary drug availability. Gloyd J J Am Vet Med Assoc; 1980 Apr; 176(7):611-4. PubMed ID: 7372533 [No Abstract] [Full Text] [Related] [Next] [New Search]